Your Search Returned 158 tagged news reports
The Obama administration on Wednesday offered an Iranian opposition group a path to get off of a U.S. terrorism blacklist, a move that would end years of high-profile campaigning from the Mujahadin-e-Khalq and infuriate Iran.
Breaking News The cooperation of the Mujahadin-e Khalq in closing its base at Camp Ashraf in Iraq will be a key factor in any decision to drop the group from a United States list of foreign terrorist organizations, US Secretary of State Hillary
On the record, the people involved insist there is no Israel element to what they say is a humanitarian endeavor to remove the movement's followers from danger. I don't see any Israel issue at all, Dershowitz told JTA in an interview, instead casting
The portrayal of women warriors have been the subject of history, mythology, culture, film, folklore and gender studies. It is time to unravel a real ongoing epic involving 21st century women warriors who have not only outwitted their past
The mysterious assassination of an Iranian nuclear scientist on 12 January, raised questions on who was responsible for a series of similar killings. Rumors initiated by pro-Iran bloggers made headlines claiming it was a "joint Mossad-MEK" operation.
Sunday February 12, 2012 Search About Salem-News.com is the premiere Independent Online Newsgroup in the United States. NBC reported two days ago that Israel teams with terror group to kill Iran's nuclear scientists. The attacks, which have killed
Ramzi Yousef, mastermind of the first attack on the World Trade Center in 1993 and nephew of 9-11 mastermind Khalid Sheikh Mohammad, was employed by the MEK as a bomb-maker. NBC News reports : Deadly attacks on Iranian nuclear scientists are being
According to an article here U.S. officials confirm that a dissident
Thank you, and thanks to everyone for joining us on such relatively short notice...Very happy to have here with us this morning Ambassador Dan Fried, who, as you know, has taken on the additional responsibility of being our special advisor on Camp
But roughly one-quarter of patients who take the medication develop a troublesome side effect: secondary skin cancers called squamous cell carcinomas...MEK inhibitor -- which blocks the other mutation -- may not only prevent this side effect, but may